These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34749347)

  • 21. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
    Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
    Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
    Miao D; Yu Y; Chen Y; Liu Y; Su G
    Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
    Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
    ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics.
    Deng Y; Zhang H
    Int J Nanomedicine; 2013; 8():1835-41. PubMed ID: 23674895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic-Covalent Hydrogel with NIR-Triggered Drug Delivery for Localized Chemo-Photothermal Combination Therapy.
    Sun P; Huang T; Wang X; Wang G; Liu Z; Chen G; Fan Q
    Biomacromolecules; 2020 Feb; 21(2):556-565. PubMed ID: 31804804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer effects of Ac‑Phe‑Lys‑PABC‑doxorubicin via mitochondria‑centered apoptosis involving reactive oxidative stress and the ERK1/2 signaling pathway in MGC‑803 cells.
    Zhong YJ; Liu SP; Firestone RA; Hong YP; Li Y
    Oncol Rep; 2013 Oct; 30(4):1681-6. PubMed ID: 23877402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
    He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
    Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
    Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
    Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin-conjugated CuS nanoparticles for efficient synergistic therapy triggered by near-infrared light.
    Bi H; Dai Y; Lv R; Zhong C; He F; Gai S; Gulzar A; Yang G; Yang P
    Dalton Trans; 2016 Mar; 45(12):5101-10. PubMed ID: 26883928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functionalised molybdenum disulfide nanosheets for co-delivery of doxorubicin and siRNA for combined chemo/gene/photothermal therapy on multidrug-resistant cancer.
    Li G; Meng F; Lu T; Wei L; Pan X; Nong Z; Wei M; Liao C; Li X
    J Pharm Pharmacol; 2021 Jul; 73(8):1128-1135. PubMed ID: 33881512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronized Chemotherapy/Photothermal Therapy/Sonodynamic Therapy of Human Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells Using a Doxorubicin-Gold Nanoclusters-Albumin Nanobioconjugate.
    Kayani Z; Heli H; Dehdari Vais R; Haghighi H; Ajdari M; Sattarahmady N
    Ultrasound Med Biol; 2024 Jun; 50(6):869-881. PubMed ID: 38538442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway.
    Zhang Z; Zhang H; Li D; Zhou X; Qin Q; Zhang Q
    J Cell Mol Med; 2021 Sep; 25(17):8159-8168. PubMed ID: 34369076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porous Au@Pt Nanoparticles: Therapeutic Platform for Tumor Chemo-Photothermal Co-Therapy and Alleviating Doxorubicin-Induced Oxidative Damage.
    Yang Q; Peng J; Xiao Y; Li W; Tan L; Xu X; Qian Z
    ACS Appl Mater Interfaces; 2018 Jan; 10(1):150-164. PubMed ID: 29251910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells.
    Gurunathan S; Raman J; Abd Malek SN; John PA; Vikineswary S
    Int J Nanomedicine; 2013; 8():4399-413. PubMed ID: 24265551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
    Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
    Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SERS-active liposome@Ag/Au nanocomposite for NIR light-driven drug release.
    Zhao Y; Zhao J; Shan G; Yan D; Chen Y; Liu Y
    Colloids Surf B Biointerfaces; 2017 Jun; 154():150-159. PubMed ID: 28334692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer Potential of Doxorubicin in Combination with Green-Synthesized Silver Nanoparticle and its Cytotoxicity Effects on Cardio-Myoblast Normal Cells.
    Saeidi J; Dolatabadi S; Esfahani MB; Saeidi M; Mohtashami M; Mokhtari K; Ghasemi A
    Anticancer Agents Med Chem; 2021; 21(14):1842-1849. PubMed ID: 33292144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis Inducing Activity of Rhinacanthin-C in Doxorubicin-Resistant Breast Cancer MCF-7 Cells.
    Chaisit S; Jianmongkol S
    Biol Pharm Bull; 2021; 44(9):1239-1246. PubMed ID: 34471052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.